IP Library Granted Patent US 10,495,635
Granted Patent B2
US 10,495,635 · App. 15/030,852 · Granted Dec 3, 2019

Testing device for testing analytes in liquid samples

Inventor: Wang Jian-Feng (Zhejiang, CN)
Assignee: Abon Biopharm (Hangzhou) Co., Ltd.
G01N33/54366B01L3/5023B01L3/523G01N33/94B01L2300/047B01L2300/048B01L2300/0825B01L2300/0832B01L2300/123B01L2400/049B01L2400/0478B01L2400/0481B01L2400/0688
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,495,635
App. No.
15/030,852
Granted
Dec 3, 2019
Kind
B2
Abstract

A testing device for testing the analytes in liquid samples, including: a test chamber ( 115 ) used to accommodate testing components ( 102 ); an injection port ( 120 ); a device for gas exchange ( 113 ) between inside and out side of the testing chamber ( 115 ). The gas pressure difference makes the liquid sample enter the testing chamber ( 115 ) automatically to complete the testing of analytes in liquid samples.

Claims (12)

1. A testing device for testing an analyte in a liquid sample, comprising:

a liquid sample collecting chamber;

a lid configured to seal the opening of the collecting chamber, the lid having a testing chamber accommodating a test element;

an injection opening disposed in the lid in fluid connection with the collecting chamber;

a gas chamber in fluid connection with the collecting chamber via the testing chamber and the injection opening,

wherein the gas chamber is configured to transition from a first configuration having an initial volume to a second configuration having a reduced volume, and resiliently transition from the second configuration back to the first configuration,

wherein the volume of the gas chamber is reduced to the reduced volume upon transition from the first configuration to the second configuration,

wherein the volume of the gas chamber returns to the initial volume upon transition from the second configuration to the first configuration, and

wherein the injection opening is upstream from the testing chamber and the gas chamber is downstream from the testing chamber and the device is operable to force liquid sample from the collecting chamber through the injection opening and into contact with the test element in the testing chamber via negative pressure generated within the testing chamber and the gas chamber upon resiliently transitioning the gas chamber from the second configuration to the first configuration as the volume of the gas chamber increases to the initial volume of the gas chamber.

2. The testing device according to claim 1 , wherein a liquid sample present in the collecting chamber seals the injection opening before transitioning from the first configuration to the second configuration or the second configuration to the first configuration.

3. The testing device according to claim 1 , wherein the gas chamber comprises elastic deformation material.

4. The testing device according to claim 1 , wherein the test element is upstream from a sample receiving area, the sample receiving area being upstream from the injection opening.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2016
From: JIAN-FENG, WANG
To: ABON BIOPHARM (HANGZHOU) CO., LTD.
Reel/Frame 038837/0603 →
Priority Claims (2)
CN 2013 1 0502781 · Oct 22, 2013 · national
CN 2013 2 0657108 U · Oct 22, 2013 · national
Continuity (1)
Related Publication 20160252503A1 · Sep 1, 2016
Cited By (1)
US 12,569,844